Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort - Poll - MDSpire

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

  • By

  • Jakob Stögbauer

  • Moritz Bewarder

  • Linda Groß

  • Lorenz Thurner

  • Klaus Fassbender

  • Rebecca Urschel

  • Einar A. Høgestøl

  • Gro O. Nygaard

  • Hanne F. Harbo

  • Olaf Stüve

  • Marc Pawlitzki

  • Sven G. Meuth

  • Martina Sester

  • Sergiu Groppa

  • Mathias Fousse

  • May 12, 2026

  • 0 min

Share

Original Source(s)

Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort

  • by Jakob Stögbauer, Moritz Bewarder, Linda Groß, Lorenz Thurner, Klaus Fassbender, Rebecca Urschel, Einar A. Høgestøl, Gro O. Nygaard, Hanne F. Harbo, Olaf Stüve, Marc Pawlitzki, Sven G. Meuth, Martina Sester, Sergiu Groppa, Mathias Fousse

  • May 12, 2026

Related Content

Listening to MS: AI-assisted speech analysis for diagnosis and fatigue prediction (COMMITMENT)

CAR T cells and T cell engagers for autoimmunity—lessons from hematology

To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization - KFF Health News